Lance Liotta, MD, PhD

Dr. Liotta and Petricoin began their proteomics collaboration in 1997, which led to the formation of the first Interagency Agreement between NCI and FDA to develop and test technologies for proteomic analysis—the study of protein activity in cells—of cancer and other diseases. Dr. Liotta currently is the professor of Life Sciences and the Co-Director of the Center for Applied Proteomics and Molecular Medicine

Faculty Profile

Emanuel Petricoin III, PhD

Dr. Emanual Petricoin III joined the FDA in 1993, following a three-year postgraduate fellowship with the agency. He currently is senior investigator in the Office of Cell Tissue and Gene Therapies in the Center for Biologics Evaluation and Research, the professor of Life Sciences, Chair of the Department of Molecular and Microbiology, and Co-Director of the Center for Applied Proteomics and Molecular Medicine

Faculty Profile